Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Sitemap: |
Title | Opexa Therapeutics - |
Description | Opexa in the Home About Opexa About Opexa Management Team Board of Directors Scientific Advisory Board Facility Contact Us Tcelna® Tcelna® Description TERMS Phase 2b O |
Keywords | N/A |
WebSite | opexatherapeutics.com |
Host IP | 108.163.221.2 |
Location | United States |
Site | Rank |
US$707,121
Last updated: 2023-05-14 07:34:40
opexatherapeutics.com has Semrush global rank of 14,968,170. opexatherapeutics.com has an estimated worth of US$ 707,121, based on its estimated Ads revenue. opexatherapeutics.com receives approximately 81,591 unique visitors each day. Its web server is located in United States, with IP address 108.163.221.2. According to SiteAdvisor, opexatherapeutics.com is safe to visit. |
Purchase/Sale Value | US$707,121 |
Daily Ads Revenue | US$653 |
Monthly Ads Revenue | US$19,582 |
Yearly Ads Revenue | US$234,982 |
Daily Unique Visitors | 5,440 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
opexatherapeutics.com. | A | 14400 | IP: 108.163.221.2 |
opexatherapeutics.com. | NS | 86400 | NS Record: ns57.superdomainzone.com. |
opexatherapeutics.com. | NS | 86400 | NS Record: ns58.superdomainzone.com. |
opexatherapeutics.com. | MX | 14400 | MX Record: 0 opexatherapeutics.com. |
opexatherapeutics.com. | TXT | 14400 | TXT Record: v=spf1 ip4:108.163.221.2 ip4:108.163.221.4 +a +mx ~all |
Home About Opexa About Opexa Management Team Board of Directors Scientific Advisory Board Facility Contact Us Tcelna® Tcelna® Description TERMS Phase 2b Overview MS Overview Publications OPX-212 OPX-212 Description Neuromyelitis Optica Clinical Trials Abili-T Clinical Study for Secondary Progressive Multiple Sclerosis Overview ImmForm® Clinical Management Tool Technology T-cell Platform Opexa cGMP Manufacturing Pipeline News & Resources Multimedia Press Releases Webcasts Publications Conference & Meeting Presentations Investor Relations Why Invest Press Releases Events & Presentations Stock Information SEC Filings Financial Reports Corporate Governance Analyst Coverage Investor FAQs Careers Working at Opexa Open Positions How to Apply Living in The Woodlands Contact Us Contact Us Home Opexa Therapeutics: Precision Immunotherapy™ Tcelna®: Personalized T-cell immunotherapy Abili-T: A phase II clinical study for patients with Secondary Progressive Multiple Sclerosis NASDAQ: OPXA: $ 0.65 |
HTTP/1.1 301 Moved Permanently Date: Thu, 23 Dec 2021 01:10:32 GMT Server: Apache Location: http://www.opexatherapeutics.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Thu, 23 Dec 2021 01:10:32 GMT Server: Apache Last-Modified: Wed, 01 Dec 2021 18:53:16 GMT Accept-Ranges: bytes Content-Length: 59036 Content-Type: text/html |
Domain Name: OPEXATHERAPEUTICS.COM Registry Domain ID: 419360628_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-04-23T13:40:14Z Creation Date: 2006-04-20T17:43:17Z Registry Expiry Date: 2022-04-20T17:43:17Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS57.SUPERDOMAINZONE.COM Name Server: NS58.SUPERDOMAINZONE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-26T08:36:39Z <<< |